Medicare AdvantageDocumentationMedium impact
MA07.058n, Sleep Disorder Testing and Positive Airway Pressure Therapy Services and Supplies
Independence Blue Cross·Sleep Medicine, Pulmonology, Internal Medicine·Medical Policy
Effective date
Sep 19, 2026
We identified it
Sep 22, 2026
Summary
Independence Blue Cross Medicare Advantage policy MA07.058n for sleep disorder testing and PAP therapy services has been updated effective 09/19/2026. The policy delegates utilization management to Carelon Medical Benefits Management and references updated Clinical Appropriateness Guidelines for Sleep Disorder Management. Minor HCPCS code narrative revisions were made to A7032 and A7046 for clarity (removing "replacement only" language and changing "only" to "each").
Action Required
By 09/19/2026: (1) Billing team must verify that all sleep disorder testing and PAP therapy claims are routed through Carelon Medical Benefits Management for utilization management review. (2) Update internal documentation requirements to ensure all sleep disorder claims include: timely provider-signed written orders, proof of delivery (commercial carrier confirmation or member signature), and medical necessity documentation per Carelon guidelines. (3) Providers must familiarize themselves with Carelon's Clinical Appropriateness Guidelines for Sleep Disorder Management at https://guidelines.carelonmedicalbenefitsmanagement.com/current-sleep-guidelines to ensure claims meet medical necessity criteria. (4) Billing system should be configured to reference Medicare guidelines (LCD/NCD) first, then apply Carelon guidelines if no Medicare guidance exists. Failure to submit required documentation and prior authorizations through Carelon will result in claim denials.